These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12757516)

  • 1. Do HLA antibodies cause hemolytic transfusion reactions or decreased RBC survival?
    Nance ST
    Transfusion; 2003 Jun; 43(6):687-90. PubMed ID: 12757516
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
    Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
    Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolytic transfusion reactions due to HLA antibodies. A prospective study combining red-cell serology with investigations of chromium-51-labelled red-cell kinetics.
    Panzer S; Püchler K; Mayr WR; Höcker P; Graninger W; Lechner K
    Lancet; 1987 Feb; 1(8531):474-8. PubMed ID: 2881040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusion reaction associated with interdonor HLA incompatibility.
    Eastlund DT; McGrath PC; Burkart P
    Vox Sang; 1988; 55(3):157-60. PubMed ID: 3266389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of anti-HLA antibodies on the electrophoretic mobility of erythrocytes].
    Levin VI; Ianovich EA; Luts LS; Ivanov EP
    Gematol Transfuziol; 1991 Mar; 36(3):7-8. PubMed ID: 2065957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and mechanisms of antibody-mediated hemolysis.
    Flegel WA
    Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
    Jiménez P; Cantón J; Collado A; Cabrera T; Serrano A; Real LM; García A; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1999 Sep; 83(1):91-7. PubMed ID: 10449614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
    Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
    Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma radiation does not prevent transfusion-induced HLA alloimmunization.
    Ohto H
    Transfusion; 1997 Aug; 37(8):878-9. PubMed ID: 9280338
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion-related acute lung injury: critical neutrophil activation by anti-HLA-A2 antibodies for endothelial permeability.
    Khoy K; Nguyen MVC; Masson D; Bardy B; Drouet C; Paclet MH
    Transfusion; 2017 Jul; 57(7):1699-1708. PubMed ID: 28608441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN; Young NG; Erickson ML; Prats I
    BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA Types with Non-Specific Binding of Negative Control Beads in Luminex Panel Reactive Antibody (PRA) Screening Assay.
    Lee N; Park HS; In JW; Roh EY; Shin S; Park KU; Song EY
    Clin Lab; 2017 Jan; 63(1):169-174. PubMed ID: 28164503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fatal case of acute hemolytic transfusion reaction caused by anti-Wr
    Espinosa A; Garvik LJ; Trung Nguyen N; Jacobsen B
    Immunohematology; 2021 Mar; 37(1):20-24. PubMed ID: 33962488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-guided depletion of anti-HLA antibody-producing cells by HLA-Fc fusion proteins.
    Webber AM; Bradstreet TR; Wang X; Guo H; Nelson CA; Fremont DH; Edelson BT; Liu C
    Blood; 2022 Oct; 140(16):1803-1815. PubMed ID: 36070233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site.
    Walker LE; Ketler TA; Houghten RA; Schulz G; Chersi A; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Jan; 82(2):539-42. PubMed ID: 3881768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.
    Strupp A; Cash K; Uehlinger J
    Transfusion; 1998; 38(11-12):1022-5. PubMed ID: 9838931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric analysis of peptides associated with the human class I MHC molecules HLA-A2.1 and HLA-B7 and identification of structural features that determine binding.
    Engelhard VH; Appella E; Benjamin DC; Bodnar WM; Cox AL; Chen Y; Henderson RA; Huczko EL; Michel H; Sakaguichi K
    Chem Immunol; 1993; 57():39-62. PubMed ID: 8260089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.